Médecins Sans Frontières interventions against kala-azar in the Sudan, 1989-2003

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 6, 2003, Pages 609-613

  Ritmeijer, Koert ^a   Davidson, R N ^a,b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Antimonials; Humanitarian aid; Leishmania donovani; Sudan; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIMONY DERIVATIVE; MILTEFOSINE; PAROMOMYCIN; STIBOGLUCONATE SODIUM; ANTIPROTOZOAL AGENT;

AGGLUTINATION TEST; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DEATH; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG INDICATION; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INCIDENCE; LABORATORY TEST; LEISHMANIA DONOVANI; LYMPHADENOPATHY; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MICROSCOPY; PARASITE IDENTIFICATION; POPULATION RESEARCH; PREDICTION; RELIABILITY; SPLENOMEGALY; SUDAN; TECHNOLOGY; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS; WAR; ANIMAL; DRUG COMBINATION; DRUG RESISTANCE;

LEISHMANIA DONOVANI; NASO HEXACANTHUS;

ANIMALS; ANTIPROTOZOAL AGENTS; DISEASE OUTBREAKS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; LEISHMANIASIS, VISCERAL; SUDAN;

EID: 22944432825     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)80047-0     Document Type: Conference Paper

References (21)

1. Badaró R. Benson D. Eulálio M.C. Freire M. Cunha S. Netto E.M. Pedral-Sampaio D. Madureira C. Burns J.M. Houghton R.L. David J.R. & Reed S.G. rK39: A cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis (VL) Journal of Infectious Diseases 173 1996 758-761
2. De Beer P. Harith A.E. Van Grootheest M. & Winkler A. Outbreak of kala-azar in the Sudan Lancet 335 1990 224
3. Griekspoor A. Sondorp E. & Vos T. Cost-effectiveness analysis of humanitarian relief interventions: Visceral leishmaniasis treatment in the Sudan Health Policy and Planning 14 1999 70-76
4. Harith A.E. Kolk A.H. Leeuwenburg J. Muigai R. Huigen E. Jelsma T. & Kager P.A. Improvement of a direct agglutination test for field studies of visceral leishmaniasis Journal of Clinical Microbiology 26 1988 1321-1325
5. Moore E. O'Flaherty D. Heuvelmans H. Seaman J. Veeken H. de Wit S. & Davidson R.N. A randomised comparison of generic sodium stibogluconate (sodium antimony gluconate, Albert David Ltd., Calcutta) and Pentostam (Glaxo Wellcome, London) for the treatment of visceral leishmaniasis in Kenya Bulletin of the World Health Organization 79 2001 388-393
6. MSF Violence, Health, and Access to Aid in Unity State/ Western Upper Nile, Sudan 2002 Médecins Sans Frontières Amsterdam
7. MSF MSF Manual for the Diagnosis and Treatment of Visceral Leishmaniasis (Kala-Azar) Under Field Conditions 2003 MSF-Holland Amsterdam
8. Perea W.A. Moren A. Ancelle T. & Sondorp E. Epidemic visceral leishmaniasis in southern Sudan Lancet ii 1989 1222-1223
9. Ritmeijer K. Veeken H. Melaku Y. Leal G. Amsalu R. Seaman J. & Davidson R.N. Ethiopian visceral leishmaniasis: Generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome Transactions of the Royal Society of Tropical Medicine and Hygiene 95 2001 668-672
10. Seaman J. Price D. Sondorp E. Moody A. Bryceson A.D.M. & Davidson R.N. Epidemic visceral leishmaniasis in Sudan: A randomised trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone Journal of Infectious Diseases 168 1993 715-720
11. Seaman J. Boer C. Wilkinson R. de Jong J. de Wilde E. Sondorp E. & Davidson R. Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions Clinical Infectious Diseases 21 1995 188-193
12. Seaman J. Mercer A.J. & Sondorp E. The epidemic of visceral leishmaniasis in Western Upper Nile, southern Sudan: Course and impact from 1984 to 1994 International Journal of Epidemiology 25 1996 862-871
13. Sundar S. Reed S.G. Singh V.P. Kumar P.C. & Murray H.W. Rapid accurate field diagnosis of Indian visceral leishmaniasis Lancet 351 1998 563-565
14. Sundar S. More D.K. Singh M.K. Singh V.P. Sharma S. Makharia A. Kumar P.C. & Murray H.W. Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic Clinical Infectious Diseases 31 2000 1104-1107
15. Sundar S. Jha T.K. Thakur C.P. Engel J. Sindermann H. Fischer C. Junge K. Bryceson A. & Berman J. Oral miltefosine for Indian visceral leishmaniasis New England Journal of Medicine 347 2002 1739-1746
16. Thomson M.C. Elnaiem D.A. Ashford R.W. & Conner S.J. Towards a kala-azar risk map for Sudan: Mapping the potential distribution of Phlebotomus orientalis using digital data of environmental variables Tropical Medicine and International Health 4 1999 105-113
17. Veeken H. Ritmeijer K. Seaman J. & Davidson R. A randomised comparison of branded sodium stibogluconate (Pentostam, Glaxo Wellcome, London) and generic sodium stibogluconate (Albert David Ltd., Calcutta) for the treatment of visceral leishmaniasis under field conditions in Sudan Tropical Medicine and International Health 5 2000 312-317
18. Veeken H. Ritmeijer K. Seaman J. & Davidson R.N. Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in Sudan Tropical Medicine and International Health 8 2003 164-167
19. Zijlstra E.E. & El-Hassan A.M. Leishmaniasis in Sudan: 3. Visceral leishmaniasis Transactions of the Royal Society of Tropical Medicine and Hygiene 95 supplement 1 2001 S1/27-S1/58
20. Zijlstra E.E. Siddig Ali M. El-Hassan A.M. El-Toum I.A. Satti M. Ghalib H.W. Sondorp E. & Winkler A. Kala-azar in displaced people from southern Sudan: Epidemiological, clinical and therapeutic findings Transactions of the Royal Society of Tropical Medicine and Hygiene 85 1991 365-369
21. Zijlstra E.E. Nur Y. Desjeux P. Khalil E.A.G. El-Hassan A.M. & Groen J. Diagnosing visceral leishmaniasis with the recombinant K39 strip test; experience from Sudan Tropical Medicine and International Health 6 2001 108-113